Magnetoliposomes with high USPIO entrapping efficiency, stability and magnetic properties.

Laboratory of Pharmaceutical Technology, Dept. of Pharmacy, School of Health Sciences, University of Patras, Patras, Greece.
Nanomedicine: nanotechnology, biology, and medicine (Impact Factor: 6.93). 06/2011; 7(5):572-9. DOI: 10.1016/j.nano.2011.06.010
Source: PubMed

ABSTRACT The DRV technique (followed by extrusion) was used for construction of hydrophilic-USPIO encapsulating liposomes. Magnetoliposomes (ML) were characterized for size, surface charge, entrapment, physical stability and magnetic properties (relaxivity). Results show that nanosized extruded-DRV MLs encapsulate higher amounts of USPIOs in comparison with sonicated vesicles. Fe (III) encapsulation efficiency (EE) is 12%, the highest reported to date for nanosized MLs. EE of MLs is influenced by ML membrane composition and polyethyleneglycol (PEG) coating. PEG-coating increases ML EE and stability; however, r(2)-to-r(1) ratios decrease (in comparison with non-PEGylated MLs). Most ML-types are efficient T2 contrast agents (because r(2)-to-r(1) ratios are higher than that of free USPIOs). Targeted MLs were formed by successfully immobilizing OX-26 monoclonal antibody on ML surface (biotin-streptavidin ligation), without significant loss of USPIOs. Targeted MLs retained their nanosize and integrity during storage for 1 month at 4 °C and up to 2 weeks at 37 °C.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The limitation of clinical use of doxorubicin is its side effects especially a cumulative dose-dependent cardiotoxicity. To overcome this, doxorubicin can be targeted to accumulate on the site of action and limit dispersion in healthy tissue. Magnetic liposomes or magnetoliposomes (MLs) are enabling targeted delivery of doxorubicin to a specific area exposed in a magnetic field. The objective of this study was synthesis and cytotoxicity study of magnetoliposomes loaded doxorubicin (MLs-Dox). MLs-Dox were prepared from phosphatidylcholine and cholesterol by a modified version of the evaporation and sonication method. The average size was 45.1 ± 7.5 nm with narrow uniform size distribution and its magnetization was 670 emu/g. Furthermore, the percentage of doxorubicin encapsulation is 81.6 ± 4.9. We found that the cytotoxicity of MLs-Dox was increased according to the strength and applied time of magnetic field. The results of this study suggested that MLs-Dox should be able to archive the good magnetic carriers for targeting doxorubicin delivery.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Magnetic core coatings modify the efficiency of nanoparticles used as contrast agents for MRI. In studies of these phenomena, care should be given to take into account possible effects of the specific micro-environment where coated nanoparticles are embedded. In the present work, the longitudinal and transverse relaxivities of superparamagnetic iron oxide nanoparticles stabilized with short-chain polyethylene glycol molecules (PEGylated SPIONs) were measured in a 7T magnetic field. PEGylated SPIONs with two different diameters (5 and 10nm) were studied. Two different PEGylated magnetoliposomes having liposome bilayer membranes composed of egg-phosphatidylcholine, cholesterol and 1,2-distearoyl-sn-glycerol-3-phosphoethanolamine-N-[methoxy PEG-2000] were also studied for their relaxivities, after being loaded with the PEGylated SPION of 5 or 10nm. This type of liposomes is known to have long residence time in bloodstream that leads to an attractive option for therapeutic applications. The influence of the magnetic core coating on the efficiency of the nanosystem as a negative contrast agent for MRI was then compared to the cumulative effect of the coating plus the specific micro-environment components. As a result, it was found that the PEGylated magnetoliposomes present a 4-fold higher efficiency as negative contrast agents for MRI than the PEGylated SPION.
    Materials Science and Engineering C 10/2014; 43C:521-526. · 2.74 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Magnetic liposomes have been frequently used as nanocarriers for targeted drug delivery and magnetic resonance imaging in recent years. Despite great potentials, their morphological/structural instability in the physiological environment still remains an intractable challenge for clinical applications. In this study, stable hybrid liposomal cerasomes (ie, liposomes partially coated with silica) which can co-encapsulate Fe3O4 nanoparticles and the anticancer drug paclitaxel were developed using thin film hydration method. Compared with the drug loaded liposomes, the paclitaxel-loaded magnetic cerasomes (PLMCs) exhibited much higher storage stability and better sustained release behavior. Cellular uptake study showed that the utilization of an external magnetic field significantly facilitated the internalization of PLMCs into cancer cells, resulting in potentiated drug efficacy of killing tumor cells. The T 2 relaxivity (r 2) of our PLMCs was much higher than that of free Fe3O4 nanoparticles, suggesting increased sensitivity in T 2-weighted imaging. Given its excellent biocompatibility also shown in the study, such dual functional PLMC is potentially a promising nanosystem for effective cancer diagnosis and therapy.
    International Journal of Nanomedicine 01/2014; 9:5103-16. · 4.20 Impact Factor


Available from
May 27, 2014

Athanasios Skouras